Publication | Open Access
Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators
24
Citations
43
References
2017
Year
bDMARD treatment sequences are cost-effective from a US societal perspective.
| Year | Citations | |
|---|---|---|
Page 1
Page 1